Hybio Pharmaceutical Co., Ltd. develops drug products. The Company manufactures and sells omeprazole sodium injection, somatostatin injection, desmopressin, antide, and other related products. Hybio Pharmaceutical also develops and sells medical testing products.
Ticker:
300199
ISIN:
CNE1000011T7
Address:
Hybio Medicine Park, (click to copy or hover over here to view full address)
CSRHub includes data on World Council for Sustainable Business Development, CSR, Carbon Disclosure Project, consequences of global warming, Sustainability, and risk management.
We Harmonize Global ESG Data
Your title or message
Sources{{sources_count}}
for
Companies{{companies_count}}
in
Countries{{countries_count}}
Your title or message
Summary of the data sources currently reporting on Hybio Pharmaceutical Co Ltd and some examples